Other Session
- Date:
- Time: 11:45am - 12:45pm
- Track: Clinical Practice
- CME/CE: 1.0
- Type: In-Person, Virtual
Sponsored by the American Academy of Neurology
Moderator: Alexander P. Auchus, MD
Learning Objectives: (1) describe how amyloid brain pathology is measured by imaging and CSF biomarkers; (2) describe how blood tests for amyloid and tau can be used in screening for dementias; (3) review the development of monoclonal antibody therapies for AD; and (4) discuss the evidence for and role of amyloid antibodies in treating AD.
| Update on Biomarkers Douglas Galasko, MD |
| Update on Monoclonal Antibody Therapies Sharon J. Sha, MD, MS |